INTRODUCTION
Pulmonary hypertension (PH) is defined as a mean pulmonary arterial pressure (PAP) of >25 mmHg at rest, with an elevation of peak systolic pressure to >30 mmHg during exercise (1, 2, 3) . Fibromuscular hypertrophy of the intima, media and adventitia occurs which narrows and finally obliterates the vessel lumen (1, 4) , reducing the cross-sectional area of the pulmonary vascular bed and increasing pulmonary vascular resistance. At presentation, up to 80% of pulmonary vessels have been obliterated, and survival from diagnosis is poor (1, 5, 6) . Pulmonary hypertension has many causes and classification has recently been updated (Table 1) (7) . Diagnosis and treatment is complex, and all patients with suspected PH should be referred to a tertiary centre. PAP is initially estimated by echocardiography, and confirmed by a diagnostic right heart catheter (8, 9) . Radiological investigations include plain chest radiograph (CXR), lung scintigraphy, computed tomography pulmonary angiogram (CTPA) and high resolution computed tomography (HRCT) of the thorax. Conventional pulmonary angiography is occasionally performed (3, 10) . CXR is often normal in PH, but abnormal findings include enlarged pulmonary arteries and pruning of peripheral vessels. Lung scintigraphy demonstrates perfusion defects, while CTPA and HRCT assess pulmonary arterial obstruction and lung parenchyma for underlying disease or changes secondary to pulmonary hypertension e.g. infarction, consolidation, mosaic perfusion patterns . Magnetic resonance imaging (MRI) aimed at quantifying pulmonary artery pressure in a non-invasive way is also being developed, but at present is mainly a research tool (8, 9, 11) . Treatment depends on disease severity. All patients receive anticoagulation (6) , and vasodilators are also usually prescribed (1, 6, 12, 13) . Surgical thromboendarterectomy is considered for chronic thromboembolic pulmonary hypertension, while heart-lung transplant is reserved for severe cases.
Right heart failure is the commonest complication and cause of death in these patients, but other recognized sequelae include central arterial atherosclerosis and thrombosis, aneurysmal pulmonary artery dilatation and lung infarction (3, 5, 14, 15) . Amongst some of our patients with chronic thromboembolic pulmonary hypertension (CTEPH), we have also observed formation of pulmonary cavities. This is a wellrecognized complication in acute thromboembolic disease (16, 17, 18, 19, 20, 21) , but cavity formation has not been previously documented in CTEPH.
The aim of this study is to assess how often we encounter cavitating lung lesions in patients with CTEPH, note thrombus position in patients with and without a cavity, note any associated infective organisms, demonstrate the findings and course of these lesions and determine whether their development is an indicator of poor outcome. Comparison with cavity characteristics in acute thromboembolic disease is also made.
MATERIALS AND METHODS
Between February 1998 and January 2006, 104 patients attended our tertiary referral unit for further investigation and management of CTEPH. All patients underwent echocardiography, ISWT, right heart catheterization, CXR and CTPA combined with HRCT. Some also had conventional pulmonary angiography and MRI. All patients who developed lung cavities were identified and a review of the notes (RB/DK) and imaging (HH/EVB) was performed. All referred patients were followed up. Thrombus position (proximal or distal) and mortality data for those with and without cavities was obtained. Of the patients who developed a cavity, symptoms at time of cavity diagnosis were noted along with inflammatory markers and sputum culture. Cavity characteristics were documented along with the radiological course in those which were followed up.
RESULTS/CASES
A total of 11of the 104 patients (10.6%) developed lung cavities. Mortality rates between those that developed cavities (three died; 27.3%) was comparable to those that did not develop cavities (25 of 93 died; 26.8%) The thrombus distribution between these two groups was also similar, with distal thrombus present in 22/93 (23.7%) patients without cavity compared to 3/11 (27.3%) patients with cavitary lesions. A summary of radiological features in shown in tables 2 & 3.
Case 1
A 35 year old woman presented with two years of progressive exertional dyspnoea. Right heart catheterisation showed significant PH with a mean PAP of 41 mmHg, and CTPA demonstrated extensive proximal thrombus. Anticoagulation and vasodilators were commenced, but a high BMI and poor lung function made her unsuitable for pulmonary endarterectomy. Sixteen months later, she was readmitted with increasing peripheral oedema and haemoptysis. Two lung cavities were seen on CT thorax lying within areas of consolidation (Fig 1a) . 1 was in the left upper lobe measuring 4cm in diameter, while the other measured 3 cm within the posterior basal segment of the right lower lobe, containing an air-fluid level. C-Reactive Protein (CRP) was elevated and sputum culture grew Pseudomonas and an Enterococcus. Clinical improvement followed antibiotic treatment. CT four months later showed increased size in both cavities, with thinner walls and partial collapse of the right basal cavity with resolution of intra-cavitary fluid (Fig 1b) . A third cavity was seen in the right upper lobe. She died while awaiting transplant assessment.
Case 2
A 57 year old woman presented with progressive exertional dyspnoea, chest tightness and intermittent haemoptysis. CTPA showed mural thrombus in the right main pulmonary artery and right heart catheterisation confirmed severe CTEPH, with a mean PAP of 72 mmHg. Anticoagulation and vasodilators were commenced. Four months later a 3cm cavity was seen on CT at the right lung base, lying within an area of consolidation ( fig.2a) . CRP was elevated and MRSA was cultured from sputum. She responded to antibiotics. MRI and MR pulmonary angiography (MRPA) were performed, demonstrating biventricular hypertrophy, massive right atrial enlargement, enlarged pulmonary trunk with slow flow and mural thrombus, and extensive pulmonary arterial stenoses and post-stenotic webs, consistent with CTEPH ( fig.2b-c) . The cavity was also seen. Five months later, CT showed the cavity had increased in size to 8x5cm, was now thick walled and contained a small amount of fluid ( fig.2d ). Serial CT and CXR follow-up of the cavity demonstrated a steady decrease in cavity size and wall thickness (fig.2e-f), with eventual cavity collapse. The patient died from complications of her disease.
Case 3
A 49 year old man developed exertional dyspnoea. A pulmonary embolus was diagnosed and he was anticoagulated. His dyspnoea did not improve, and right heart catheterisation showed significant PH with a mean PAP of 44 mmHg. CTPA demonstrated thrombus in the right central pulmonary arteries. Anticoagulation and vasodilators were commenced. He was readmitted, four months later, with cough, haemoptysis and worsening dyspnoea. A large cavity was seen in the right midzone on CXR ( fig.3a) . CTPA confirmed this to be thickwalled, lying within an area of consolidation in the apical segment of the right lower lobe (Fig.3b) . CRP was elevated with pseudomonas on sputum culture. Antibiotics produced clinical improvement with a decrease in cavity size within two weeks and complete resolution after four weeks. Subsequently, he underwent successful pulmonary endarterectomy.
Case 4
A 66 year old man was referred with progressive dyspnoea following a previous pulmonary embolus. Right heart catheterisation showed a mean PAP of 53 mmHg. CTPA and conventional pulmonary angiography demonstrated widespread segmental embolic disease. MRI showed acute tapering of vessels, vascular cut-off within the right middle lobe and lingula, and slow flow within the main pulmonary trunk. After fifteen months, he presented acutely with increasing dyspnoea and a productive cough. He was afebrile, but CRP was elevated and CXR revealed bilateral upper zone consolidation. Sputum culture was negative. CT thorax confirmed consolidation in the superior segment of the left lower lobe, and the right upper lobe where there was a small cavity. Antibiotics were prescribed, and repeat CT two months later showed resolution of the cavity with replacement by a linear scar. The patient died from disease complications.
Case 5
A 55 year old man with an atrial septal defect and associated Eisenmenger syndrome developed progressive exertional dyspnoea with intermittent haemoptysis. Echocardiography was suggestive of significant pulmonary hypertension, but right heart catheterisation was not performed. One year later, he was admitted with worsening dyspnoea and right-sided chest pain. Right upper lobe consolidation containing a 6 cm cavity was seen on CXR, along with marked pruning of the right upper lobe pulmonary artery ( fig.4a ). CTPA demonstrated a cavity with well-defined walls and extensive thrombus in the right main and upper pulmonary arteries (Fig.4b) . CTEPH was diagnosed. CRP was elevated and sputum cultures were negative. Antibiotics and warfarin produced a good clinical response. A repeat CXR five weeks later showed a small decrease in size of both the area of consolidation and the cavity but six months on, there was little further change. He is currently on the waiting list for transplantation.
Case 6
A 43 year old man developed a swollen leg and exertional dyspnoea. Deep venous thrombosis was confirmed by Duplex ultrasonography and lung scintigraphy demonstrated multiple bilateral defects. Lifelong anticoagulation was commenced, but he remained breathless on exertion. Right heart catheterisation demonstrated a mean PAP of 34 mmHg with a dramatic increase on exercise to 68mmHg. CTPA performed on the same admission for clinical work-up showed thrombus within the inferior lingular, right middle lobe and right lower lobe medial basal segmental pulmonary arteries, and a cavity in the apical segment of the left upper lobe. CRP was normal. The patient is awaiting pulmonary endarterectomy.
Case 7
A 69 year old man presented with exertional dyspnoea and an echocardiogram suggestive of pulmonary hypertension. Warfarin was commenced and right heart catheterisation confirmed significant PH with a mean PAP of 49 mmHg. Conventional pulmonary angiogram demonstrated surgically inaccessible chronic thromboembolic disease. Vasodilators were commenced. 16 months after initial diagnosis, he developed a productive cough, and a CXR showed a cavity within right upper lobe consolidation. He was treated with antibiotics and subsequent CT thorax showed cavity resolution with minor residual scarring.
Case 8
A 43 year old lady presented with exertional dyspnoea. 3 months later, she was admitted with worsening breathlessness, cough and pleuritic chest pain. CXR showed right mid zone consolidation and an echocardiogram suggested pulmonary hypertension. CTPA demonstrated pulmonary emboli in the arteries leading to two cavities in the right mid zone, and some lung fibrosis. An initial diagnosis of pulmonary embolism was made and right heart catheterisation confirmed PH with a mean PAP of 53 mmHg. Warfarin and antibiotics were prescribed. Follow-up CT thorax 18 months later demonstrated cavity resolution, with an increase in fibrotic changes.
Case 9
A 70 year old lady with a previous history of pulmonary embolism was admitted with a short history of exertional dyspnoea. An echocardiogram suggested pulmonary hypertension. This was confirmed on right heart catheterisation with a mean PAP of 67 mmHg. A CTPA on the same admission showed proximal thromboembolic disease, while HRCT revealed mosaic perfusion and a small cavity at the right apex. Anticoagulation and vasodilators were commenced, and she is currently awaiting pulmonary endarterectomy.
Case 10
A 51 year old man presented with increasing exertional dyspnoea. CTPA demonstrated distal pulmonary arterial thrombus and a 4cm thick-walled cavity in the base of the right lower lobe, and right heart catheterisation confirmed PH with a mean PAP of 58mmHg. CRP and sputum culture were negative. Antibiotics and vasodilators were commenced and the patient is currently under follow-up.
Case 11
A 77 year old lady presented with progressive breathlessness. Following an acute deterioration, CTPA showed extensive proximal pulmonary arterial thromboembolic disease (fig.5 ). Initial improvement followed anticoagulation, but then her symptoms deteriorated, with increasing breathlessness and a productive cough. CXR demonstrated multiple lung cavities, and repeat CTPA reconfirmed extensive thromboembolism. After two weeks of antibiotic therapy, she underwent right heart catheterisation which confirmed CTEPH, with a mean PAP of 35 mmHg. Vasodilators were commenced and she is awaiting pulmonary endarterectomy.
DISCUSSION
Pulmonary cavities form when necrotic lung parenchyma communicates with a patent airway. Most commonly they occur as abscesses in the context of infection, or in tumours. Other unusual associations include inflammatory causes e.g. rheumatoid arthritis and Wegeners granulomatosis, following trauma, and in pulmonary infarction when tissue necrosis is considered rare due to dual blood supply from both pulmonary and bronchial arteries. There are a few papers describing pulmonary cavities in the context of pulmonary thromboembolism. They all refer to patients with acute pulmonary embolism and are based on post-mortem studies combined with CXR and lung scintigraphy findings (16,17,18,20,21). As far as we are aware, studies on the incidence of pulmonary cavities in chronic thromboembolic pulmonary disease have not been previously reported in the literature.
Imaging findings in CTEPH are often non-specific. The CXR frequently appears normal. Abnormalities include enlarged pulmonary arteries, pruning of peripheral vessels, and pulmonary infarcts, which tend to be subpleural, peripheral, wedge-shaped areas of opacification. The most common radiological changes seen on CT are mosaic perfusion and micronodular disease (15), along with an enlarged main pulmonary artery and abrupt tapering of segmental vessels. Intimal covering of incompletely resolved thrombus leads to mural pulmonary arterial thrombus, which may calcify over time. The presence of mural thrombus results in increased right ventricular strain due to flow-obstruction and ultimately leads to right heart failure and death. (5, 14) .
In acute pulmonary embolism, lung infarction occurs in less than 15% of cases, and of these, only 5% cavitate (18). The prevalence of cavity formation as described from postmortem studies is 3.4% (22,23,24). More than 75% of cavities develop in the mid and upper zones (apical and posterior segments upper lobes and superior segments lower lobes), and they more commonly appear in the right lung. (16,17) . This distribution is opposite to the common position of emboli and non-cavitary infarcts which occur more frequently in the lower zones, possibly due to higher blood flow there(19). Cavities are more commonly single than multiple (16), may be thin or thick-walled (25), and usually occur in the presence of infection (16,17). Cavitation in a sterile infarct is exceedingly uncommon, and other causes should be considered(16). The natural history of cavities seen in acute PE shows that some resolve, leaving a linear scar with associated pleural thickening, while others remain. Maturing cavities tend to enlarge with increasing uniformity and thinning of the wall before becoming smaller or resolving. Observation suggests that patients developing more than one cavity have an increased mortality, possibly as a reflection of disease severity (16).
In this cohort of 104 patients with CTEPH, 10.9% developed a cavity. 8 had a single cavity, 1 patient had 2 cavities and 2 patients developed 3 cavities. More cavities were found in the upper lobes (8), while 5 were in the lung bases and 3 in the apical segment of the lower lobe. Whilst these findings mirror the number of cavities and their location and distribution as described in acute thromboembolic disease, they also suggest that cavity formation is approximately three times more common than seen in acute PE (10.9% vs 3.4%). Most of the cavities had thick, well-defined walls and surrounding consolidation at diagnosis with one containing an air-fluid level. The two cavities without surrounding consolidation were found during routine imaging, so preexisting consolidation was unknown. Follow-up imaging was performed in seven patients with a total of nine cavities. Surrounding consolidation resolved in all cases. During follow-up, the natural progression of the cavities in our CTEPH cohort mirrored that described in acute disease, with either complete or partial resolution and wall-thinning in most cases. Five of the nine cavities also showed an initial increase in size. Cavity diagnosis in seven patients followed an acute exacerbation of symptoms including increased breathlessness, cough and pyrexia, with the remaining cavities being diagnosed during routine workup. Three patients had positive sputum cultures and an elevated CRP, two patients had an elevated CRP with negative sputum culture, two patients had a normal CRP and no sputum culture, and the reminder had neither inflammatory markers nor sputum culture performed. Ten of the patients were treated with antibiotics with clinical or radiological improvement. One patient had normal CRP, sputum cultures were not obtained and antibiotics were not prescribed. The cavity resolved spontaneously, suggesting that this was a true sterile cavity.
Comparing thrombus position between patients with and without cavity formation, proximal mural thrombus was seen in 65 of the 93 patients who did not form a cavity (69.9%) compared to 8 of the 11 patients who did (72.2%). Conversely, 22 of the patients without a cavity had distal thrombus (23.7%) compared to three of the patients with (27.3%). Due to the small numbers involved, it was not possible to perform meaningful statistics on these figures, however, no major differences were observed. Six of the patients without a cavity did not have mural thrombus, implying that CTEPH was related to distal disease.
Cavity development was not associated with an increase in mortality (26.8% vs 27.3%). Of the three patients who died, one developed multiple cavities. However two other patients with multiple cavities remain alive, suggesting that development of multiple cavities is not necessarily a predictor of mortality.
Many features of the cavities occurring in our series of CTEPH patients concur with those reported in the literature in acute pulmonary embolism. However, our study suggests that cavity formation is 3 times more common in chronic thromboembolic disease, and all our cases were associated with pulmonary arterial thrombus and other evidence of severe disease. Whilst infection or inflammation was not proved in all cases, many of the cavities were diagnosed following an exacerbation of symptoms, with improvement following a course of antibiotics. Proximal or distal thrombus position does not seem to affect the likelihood of a cavity developing, and the presence of a cavity does not seem to be associated with an increased mortality. We therefore conclude that cavity formation is a recognised complication of CTEPH, and is more commonly encountered than in acute thromboembolic disease. Treatment with antibiotics is recommended regardless of sputum culture results and follow-up with serial CXR or low dose CT thorax should be performed to ensure partial or full resolution.
TEACHING POINT
Cavity formation is a recognised complication of CTEPH, which is more commonly encountered than in acute thromboembolic disease, and cavity presence may serve as an indicator of disease severity but not as a predictor of mortality. 
